Medication info

Telmiaplus Tablet 40/5 mg

Prescription medicationOralExpired
Ingredient · strength
Telmisartan Powder 23.9%›167.36mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
Yuyu Pharmaceutical Co., Ltd.
Appearance
This is a white and light gray double tablet that is convex on both sides.
Packaging
30 tablets/PTP [30 tablets (10 tablets/Alu-Alu X 3)]
Approval status
Expired

MFDS item code 201902127 · Approved 2019.04.08

This product's status changed to Expired on 2024.04.08. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension not controlled by monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water regardless of meals. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the doses of the individual components (amlodipine or telmisartan) be adjusted. However, if blood pressure is not controlled with an individual component as follows, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product with the same amount of each active ingredient) for convenience (limited to this medicine 40/5 mg). ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of telmisartan should not exceed 40 mg. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring caution’). In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
Child dose
The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
Yuyu Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled by monotherapy

  • Essential Hypertension
View approved original text

This medication may be effective for patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy of amlodipine or telmisartan. In such cases, the two drugs can be combined to lower blood pressure more stably. This helps reduce the risk of complications associated with hypertension. Patients who find it difficult to manage their blood pressure can also expect positive effects on blood pressure control with continuous use. This medication is specifically used for the treatment of essential hypertension.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water regardless of meals. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the doses of the individual components (amlodipine or telmisartan) be adjusted. However, if blood pressure is not controlled with an individual component as follows, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product with the same amount of each active ingredient) for convenience (limited to this medicine 40/5 mg). ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of telmisartan should not exceed 40 mg. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring caution’). In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.

Child dose

The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Precautions

This medication can pose serious risks to the fetus, especially during the 2nd and 3rd trimester of pregnancy, and should not be taken by pregnant women or women who may become pregnant. Use of this medication is contraindicated or requires caution for patients with certain conditions. For example, patients with liver disorders, severe hypotension, cardiac diseases, obstructive biliary diseases, and those with severely impaired kidney function or diabetes should not use this medication. As this medication lowers blood pressure, it may cause hypotension, and if symptoms of hypotension occur, appropriate measures should be taken immediately. Furthermore, there is a risk of hyperkalemia, which is an increase in potassium levels in the blood, so potassium levels should be regularly checked, and caution should be taken when combining with medications or supplements high in potassium. For patients with reduced kidney function, there is a risk of worsening renal function, and serum creatinine and potassium levels should be monitored periodically. Side effects such as dizziness, drowsiness, visual disturbances, palpitations, and edema can commonly occur, and care should be taken when driving or operating machinery. Since this medication has a strong blood pressure-lowering effect, patients with cardiovascular diseases should be cautious as excessive blood pressure reduction may increase the risk of myocardial infarction or stroke. This medication may interact with other drugs, so patients should inform their doctor or pharmacist if they are taking other medications, especially when used with lithium, digoxin, warfarin, non-steroidal anti-inflammatory drugs, etc. Pregnant or breastfeeding women should not take this medication and must stop immediately if pregnancy is confirmed. The safety and efficacy of this medication in pediatric patients have not been sufficiently established, so it is not recommended. In case of overdose, symptoms such as hypotension, dizziness, and cardiac abnormalities may occur, and prompt medical attention should be sought. This medication should be kept out of reach of children, and it is advisable not to transfer it to other containers to maintain the product's quality.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 99 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylaxis
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusional state
  • drowsiness
  • headache
  • migraine
  • sensory disturbances
  • sensory impairment
  • taste disturbances
  • tremor
  • extrapyramidal symptoms
  • muscle rigidity
  • visual impairment
  • diplopia
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • shortness of breath
  • rhinitis
  • changes in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver function abnormality
  • liver impairment
  • hepatitis
  • jaundice
  • increased liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • hair loss
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug eruption
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • urinary disorders
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • asthenia
  • fatigue
  • chest pain
  • illness perception
  • influenza-like illness
  • increased liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that protects it from light. Additionally, it should be kept at room temperature, not too hot or too cold, between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

This is a white and light gray double tablet that is convex on both sides.

Package unit

30 tablets/PTP [30 tablets (10 tablets/Alu-Alu X 3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.